DNA-damage assays, quantifying the initial number of DNA double-strand breaks induced by radiation, have been proposed as a predictive test for radiation-induced toxicity. Determination of radiation-induced apoptosis in peripheral blood lymphocytes by flow cytometry analysis has also been proposed as an approach for predicting normal tissue responses following radiotherapy. The aim of the present study was to explore the association between initial DNA damage, estimated by the number of double-strand breaks induced by a given radiation dose, and the radio-induced apoptosis rates observed.
Peripheral blood lymphocytes were taken from 26 consecutive patients with locally advanced breast carcinoma. Radiosensitivity of lymphocytes was quantified as the initial number of DNA double-strand breaks induced per Gy and per DNA unit (200 Mbp). Radio-induced apoptosis at 1, 2 and 8 Gy was measured by flow cytometry using annexin V/propidium iodide.
Radiation-induced apoptosis increased in order to radiation dose and data fitted to a semi logarithmic mathematical model. A positive correlation was found among radio-induced apoptosis values at different radiation doses: 1, 2 and 8 Gy (p < 0.0001 in all cases). Mean DSB/Gy/DNA unit obtained was 1.70 ± 0.83 (range 0.63-4.08; median, 1.46). A statistically significant inverse correlation was found between initial damage to DNA and radio-induced apoptosis at 1 Gy (p = 0.034). A trend toward 2 Gy (p = 0.057) and 8 Gy (p = 0.067) was observed after 24 hours of incubation.
An inverse association was observed for the first time between these variables, both considered as predictive factors to radiation toxicity.
Radiation induced normal tissue damage is the most important limitation for the delivery of a high potentially curative radiation dose. Radiation doses are limited by the tolerance of normal tissues included in the treatment volume. Intrinsic variations in radiosensitivity determine most of the individual differences in normal tissue damage [1–3]. It is possible to determine the individual radiosensitivity before radiotherapy (RT) [4, 5]. If intrinsic differences in individual radiosensitivity were responsible for the variation in severity of early or late radio-induced toxicity [6–9], we could adjust the radiation dose to be delivered. An association between DNA-damage assays, quantifying the initial number of DNA double-strand breaks (DSB) induced by radiation, and radiation-toxicity has been reported [10, 11]. Increasing numbers of radiation induced DSB were related to severe late toxicity in breast cancer patients . Determination of radiation-induced apoptosis (RIA) in peripheral blood lymphocytes (PBLs) by flow cytometry analysis has been proposed as a possible prediction value of normal tissue responses after RT [12, 13]. RIA was predictive of late toxicity in several tumour locations [14–16]. Patients suffering of late toxicity after RT showed reduced rates of RIA. Furthermore, patients affected by the Ataxia-Telangiectasia (AT) syndrome showed the lowest rates of RIA. Defective apoptotic response to radiation in the PBLs of those sensitive patients could help to explain this association. As described above, late toxicity in breast cancer patients treated with radiation therapy has been related to increased radiosensitivity of lymphocytes, as shown by increased number of DSB/Gy/DNA unit, and reduced RIA. According to this, sensitive patients would show increased number of DSB and reduced RIA as results of defective apoptotic processing of the initial damage induced by x-rays. Considering the above background and observations, the aim of the present study was to analyze if there was any statistical relation between initial DNA damage, estimated by the number of DSB, and the apoptotic rates observed estimated by the amount of RIA.
PBLs were taken from 26 consecutive patients with locally advanced breast carcinoma (stage IIIa-IIIb), diagnosed and treated in our institution, and given inform consent. All patients were referred to receive high-dose hyperfractionated radical radiotherapy as follows: 60 Gy to the whole breast over a period of 5 weeks in two daily fractions of 1.2 Gy separated by at least 6 h on 5 days each week, and followed by a boost of 21.6 Gy to a total dose of 81.6 Gy. The study was approved by the Research & Ethics Committee of our institution. Mean age of patients was 57.62 ± 12.99 years (range 30-83), 69.2% of them were menopause women.
Apoptosis assay and flow cytometry
RIA analyses were performed as previously reported [13, 17]. PBLs were irradiated with 0, 1, 2 and 8 Gy. After irradiation, samples were incubated for 24 hours at 37°C and 5% CO2. After extraction of cellular pellet, it was resuspended in 100 μl Annexin V buffer Kit (Pharmingen, Becton Dickinson). After the addition of 4 μl of Annexin-V-FITC and 10 μl of propidium iodure (PI), cells were incubated during 15 minutes at room temperature in the dark. Finally, 400 μl of Annexin V buffer Kit were added. Every assay was made in triplicate. The flow cytometry analysis was performed in a FACScalibur (Becton Dickinson, San José, CA) using a 488 nm argon laser. Each sample was analyzed using 5000 events/sample acquired in list mode by a Macintosh Quadra 650 minicomputer (Apple computer Inc., Cupertino, CA). Data were analyzed using the CellQuest program (Becton Dickinson, San José, CA) calculating early and late apoptosis levels. RIA is defined as the percentage of total PBLs death induced by the radiation dose minus the spontaneous cell death (control, 0 Gy).
DNA damage assay
Data related to initial DNA damage were obtained from our files . Shortly, mononuclear cells were isolated from blood of patients, resuspended in cold DMEM, and mixed with 1% ultra-low-melting-point agarose to obtain 250 μl plugs. Irradiation on ice was performed using a 60Co source (rate dose 1.5 Gy/min, approximately) as previously reported . Plugs were held 1 hour at 4°C and incubated at 37°C for 24 hours. The study of initial DNA damage was completed in the University of Granada (Spain). Initial radiation-induced DNA damage in PBLs was measured as previously described  and was considered an individual indicator of the molecular radiosensitivity of normal cells.
Statistical analyses were performed using the SPSS Statistical Package (version 15.0 for Windows) as previously reported [10, 13, 18]. The cut-off value for DSB/Gy/DNA unit was the median. Additional cut-off values studied were the tertiles of the distribution. All tests were two sided and statistical significance level was established for a p value less than 0.05.
Data of RIA were available in all 26 breast cancer patients, as shown in Table 1. RIA values increased with radiation dose (Table 1), and data fitted to a semi-logarithmic equation as follows: RIA = α + β ln(Gy), confirming our previously observations [13, 17, 19]. The increments in RIA were defined by two constants: the coefficient in origin α (as the origin of the curve in the Y axis determining the spontaneous apoptosis); and the coefficient β defining the slope of the curve. α and β followed a normal distribution (Kolmogorov-Smirnov test, p > 0.05). Mean of β was 7.93 ± 2.68 standard deviation (range 1.64-26.63; median, 12.64); mean of β was 7.93 ± 2.68 (range 3.18-12.57; median, 7.85) (Table 1). In this way, we were able to establish an individual radiosensitivity value defined by two constants: α as the spontaneous apoptotic rate, and β as the percentage of RIA per Gy. A good correlation was found among RIA data at different doses: 1 vs. 2 Gy, R2 = 0.978 (p < 0.0001); 1 vs. 8 Gy, R2 = 0.883 (p < 0.0001); 2 vs. 8 Gy, R2 = 0.914 (p < 0.0001) (Spearman Rho test, Figure 1). The experimental data showed an excellent fit to the described model (median regression coefficient at 24 h was 99.58).
Apoptosis data obtained after the irradiation of PBLs at 1, 2 and 8 Gy
Mean ± SD
RIA 1 Gy
13.33 ± 7.26
RIA 2 Gy
18.20 ± 7.82
RIA 8 Gy
29.70 ± 10.05
1.70 ± 0.83
Defined model data
13.08 ± 7.21
7.93 ± 2.68
98.18 ± 4.58
Relation to initial DNA damage
Mean ± standard deviation of DSB/Gy/DNA unit, obtained from our files  was 1.70 ± 0.83 (range 0.63-4.08; median, 1.46). No relation was found between the number of DSB and the RIA at 1 (p = 0.406), 2 (p = 0.592) and 8 Gy (p = 0.619). In the same way, no relation was found between the number of DSB and the model coefficient variables α (p = 0.457) and β (p = 0.901), when they were analyzed as continuous variables (Pearson test used in all correlations). When DSB values were segregated in two groups (the lower third against the two upper thirds of the distribution), a modest inverse correlation was found, reaching statistical significance for RIA at 1 Gy (p = 0.034). A similar trend was found for RIA at 2 (p = 0.057) and 8 Gy (p = 0.067) (Figure 2). α values also showed an inverse correlation with DSB, that reached statistical significance (p = 0.041). No relation was found between the number of DSB and β constant.
We established for the first time, a statistical association between initial DNA damage, measured as DSB, and RIA. Ionizing radiation (IR) kills cells by damaging the structure and function of genomic DNA. The response of cells to this damage and their ability to restore DNA sequence integrity remains unclear. Intrinsic radiosensitivity is correlated in a first approach to the ability of the cell to detect and repair DNA damages. DSB can be induced by a variety of DNA damaging agents, such as x-rays . Differences in cell survival may be related to the number of initial DNA DSB, the DSB rejoining rate, or the level of residual DNA damage [11, 21–24]. Wide variation in the level of initial radiation-induced DNA damage suggests that variation in cell radiosensitivity can be detected in vitro using radiosensitivity assays on PBLs from normal tissues of cancer patients prior to RT . Patients with radiosensitive PBLs presented a significant increased risk for develop late complications . Increasing numbers of radiation induced DSB were related with severe late toxicity reactions in breast cancer patients . In the other hand, RIA values, that fitted to a semi logarithmic model defined by α and β constants, increased with radiation dose . Previously studies were uniformly positive towards a relation between RIA and radiation toxicity . In fact, patients suffering of late toxicity after RT showed reduced levels of RIA. The mechanism behind the relationship between increased radiation toxicity and reduced apoptotic response in PBLs is still unclear. Thus, lymphocytes from patients who suffered different syndromes related with radiosensitivity (i.e., Ataxia-telangiectasia, Bloom syndrome, or Fanconi anaemia) showed absence of induction of p53 [26, 27] and lower levels of Bax . This failure in the induction of the apoptosis response in lymphocytes has been related with late toxicity . So, defective apoptotic response to radiation in PBLs could help to explain this inverse relation . We report here for the first time a statistical association between these two predictive values for radiation toxicity. Lowest values of initial DNA damage were related to higher values of RIA, at the same radiation dose. This relation was also observed between DSB and the spontaneous apoptosis of cells (estimated by the α constant). Cell response to x-rays is individual, and the amount of initial DNA damage depends on each patient. The two main mechanisms of DSB repair are 1) non-homologous end joining (NHEJ) and homologous recombination repair (HRR) [29, 30], and 2) cell-cycle checkpoints that provide time for repair and apoptosis . Depending on the severity of the DNA damage, cells may undergo apoptosis instead of attempting to repair the damage . Regulation of RIA and cell cycle arrests is achieved primarily through p53 phosphorylation by ATM protein . T-lymphocytes from AT patients display severely compromised apoptotic response, as well as non-induction of p53 after exposure to IR . Moreover, PBLs from AT patients are characterized by an elevated spontaneous level of apoptotic cells compared to normal ones . Extremely radiosensitive patients have abnormalities in their ability to recognize or repair the DNA DSB typically induced by IR . Gene expression profile of irradiated PBLs showed that the majority of the strongly activated genes were p53 targets involved in DNA repair and apoptosis . The level of BAX activation correlated with the sensitivity of the cells to radiation . A link between RIA and cellular response to DNA DSB arises because there are many proteins common to the execution of both processes. Anyhow, there are yet unidentified proteins or complexes that regulate the cross-talk between the mutually exclusive pathways of maintenance of life and initiation of death . How these pathways are integrated to provide a concerted response to DSB is very complex, and could help to understand the inverse relation between the initial DNA damage to IR and RIA.
A statistical inverse association was observed for the first time between DNA-DSB and RIA in 26 patients diagnosed with locally advanced breast cancer. However, these results must be verified in larger series of patients.
List of abbreviations
Peripheral Blood Lymphocytes
This work was subsidized by Fundación del Instituto Canario de Investigación del Cáncer (FICIC). LAHH and EB were supported by a grant from the Instituto Canario de Investigación del Cáncer (ICIC).
Radiation Oncology Department, Hospital Universitario de Gran Canaria Dr. Negrín
Instituto Canario de Investigación del Cáncer (ICIC), Instituto Canario de Investigación del Cáncer (ICIC)
Clinical Sciences Department, Universidad de Las Palmas de Gran Canaria
Immunology Department, Hospital Universitario de Gran Canaria Dr. Negrín
Radiology Department, Hospital Universitario San Cecilio, Universidad de Granada
Guirado D, Ruiz de Almodovar JM: Prediction of normal tissue response and individualization of doses in radiotherapy.Phys Med Biol 2003, 48: 3213-3223. 10.1088/0031-9155/48/19/008View ArticlePubMedGoogle Scholar
Moody AM, Mayles WP, Bliss JM, A'Hern RP, Owen JR, Regan J, Broad B, Yarnold JR: The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity.Radiother Oncol 1994, 33: 106-112. 10.1016/0167-8140(94)90063-9View ArticlePubMedGoogle Scholar
Turesson I, Nyman J, Holmberg E, Oden A: Prognostic factors for acute and late skin reactions in radiotherapy patients.Int J Radiat Oncol Biol Phys 1996, 36: 1065-1075.View ArticlePubMedGoogle Scholar
Lopez E, Guerrero R, Nunez MI, del Moral R, Villalobos M, Martinez-Galan J, Valenzuela MT, Munoz-Gamez JA, Oliver FJ, Martin-Oliva D, Ruiz de Almodovar JM: Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes.Breast Cancer Res 2005, 7: R690-698. 10.1186/bcr1277PubMed CentralView ArticlePubMedGoogle Scholar
McMillan TJ, Tobi S, Mateos S, Lemon C: The use of DNA double-strand break quantification in radiotherapy.Int J Radiat Oncol Biol Phys 2001, 49: 373-377. 10.1016/S0360-3016(00)01467-XView ArticlePubMedGoogle Scholar
Baumann M, Holscher T, Begg AC: Towards genetic prediction of radiation responses: ESTRO's GENEPI project.Radiother Oncol 2003, 69: 121-125. 10.1016/j.radonc.2003.08.006View ArticlePubMedGoogle Scholar
Bentzen SM, Tucker SL: Individualization of radiotherapy dose prescriptions by means of an in vitro radiosensitivity assay.Radiother Oncol 1998, 46: 216-218. 10.1016/S0167-8140(97)00226-0View ArticlePubMedGoogle Scholar
Mackay RI, Hendry JH: The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.Radiother Oncol 1999, 50: 67-75. 10.1016/S0167-8140(98)00132-7View ArticlePubMedGoogle Scholar
Nunez MI, McMillan TJ, Valenzuela MT, Ruiz de Almodovar JM, Pedraza V: Relationship between DNA damage, rejoining and cell killing by radiation in mammalian cells.Radiother Oncol 1996, 39: 155-165. 10.1016/0167-8140(96)01732-XView ArticlePubMedGoogle Scholar
Pinar B, Lara PC, Lloret M, Bordon E, Nunez MI, Villalobos M, Guerrero R, Luna JD, Ruiz de Almodovar JM: Radiation-induced DNA damage as a predictor of long-term toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy.Radiat Res 2007, 168: 415-422. 10.1667/RR0746.1View ArticlePubMedGoogle Scholar
Ruiz de Almodovar JM, Guirado D, Isabel Nunez M, Lopez E, Guerrero R, Valenzuela MT, Villalobos M, del Moral R: Individualization of radiotherapy in breast cancer patients: possible usefulness of a DNA damage assay to measure normal cell radiosensitivity.Radiother Oncol 2002, 62: 327-333. 10.1016/S0167-8140(01)00490-XView ArticlePubMedGoogle Scholar
Barber JB, West CM, Kiltie AE, Roberts SA, Scott D: Detection of individual differences in radiation-induced apoptosis of peripheral blood lymphocytes in normal individuals, ataxia telangiectasia homozygotes and heterozygotes, and breast cancer patients after radiotherapy.Radiat Res 2000, 153: 570-578. 10.1667/0033-7587(2000)153[0570:DOIDIR]2.0.CO;2View ArticlePubMedGoogle Scholar
Bordon E, Henriquez Hernandez LA, Lara PC, Pinar B, Fontes F, Rodriguez Gallego C, Lloret M: Prediction of clinical toxicity in localized cervical carcinoma by radio-induced apoptosis study in peripheral blood lymphocytes (PBLs).Radiat Oncol 2009, 4: 58. 10.1186/1748-717X-4-58PubMed CentralView ArticlePubMedGoogle Scholar
Crompton NE, Miralbell R, Rutz HP, Ersoy F, Sanal O, Wellmann D, Bieri S, Coucke PA, Emery GC, Shi YQ, et al.: Altered apoptotic profiles in irradiated patients with increased toxicity.Int J Radiat Oncol Biol Phys 1999, 45: 707-714.View ArticlePubMedGoogle Scholar
Crompton NE, Shi YQ, Emery GC, Wisser L, Blattmann H, Maier A, Li L, Schindler D, Ozsahin H, Ozsahin M: Sources of variation in patient response to radiation treatment.Int J Radiat Oncol Biol Phys 2001, 49: 547-554. 10.1016/S0360-3016(00)01477-2View ArticlePubMedGoogle Scholar
Ozsahin M, Crompton NE, Gourgou S, Kramar A, Li L, Shi Y, Sozzi WJ, Zouhair A, Mirimanoff RO, Azria D: CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients.Clin Cancer Res 2005, 11: 7426-7433. 10.1158/1078-0432.CCR-04-2634View ArticlePubMedGoogle Scholar
Bordon E, Henriquez-Hernandez LA, Lara PC, Ruiz A, Pinar B, Rodriguez-Gallego C, Lloret M: Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs).Radiat Oncol 2010, 5: 4. 10.1186/1748-717X-5-4PubMed CentralView ArticlePubMedGoogle Scholar
Nunez MI, Guerrero MR, Lopez E, del Moral MR, Valenzuela MT, Siles E, Villalobos M, Pedraza V, Peacock JH, Ruiz de Almodovar JM: DNA damage and prediction of radiation response in lymphocytes and epidermal skin human cells.Int J Cancer 1998, 76: 354-361. 10.1002/(SICI)1097-0215(19980504)76:3<354::AID-IJC12>3.0.CO;2-BView ArticlePubMedGoogle Scholar
Saavedra MM, Henriquez-Hernandez LA, Lara PC, Pinar B, Rodriguez-Gallego C, Lloret M: Amifostine Modulates Radio-induced Apoptosis of Peripheral Blood Lymphocytes in Head and Neck Cancer Patients.J Radiat Res (Tokyo) 2010.Google Scholar
Ralhan R, Kaur J, Kreienberg R, Wiesmuller L: Links between DNA double strand break repair and breast cancer: accumulating evidence from both familial and nonfamilial cases.Cancer Lett 2007, 248: 1-17. 10.1016/j.canlet.2006.06.004View ArticlePubMedGoogle Scholar
Dickson J, Magee B, Stewart A, West CM: Relationship between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiation reactions: a comparison of training and validation cohorts of breast cancer patients.Radiother Oncol 2002, 62: 321-326. 10.1016/S0167-8140(01)00432-7View ArticlePubMedGoogle Scholar
Hoeller U, Borgmann K, Bonacker M, Kuhlmey A, Bajrovic A, Jung H, Alberti W, Dikomey E: Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer.Radiother Oncol 2003, 69: 137-144. 10.1016/j.radonc.2003.10.001View ArticlePubMedGoogle Scholar
Kiltie AE, Orton CJ, Ryan AJ, Roberts SA, Marples B, Davidson SE, Hunter RD, Margison GP, West CM, Hendry JH: A correlation between residual DNA double-strand breaks and clonogenic measurements of radiosensitivity in fibroblasts from preradiotherapy cervix cancer patients.Int J Radiat Oncol Biol Phys 1997, 39: 1137-1144.View ArticlePubMedGoogle Scholar
Zhou PK, Sproston AR, Marples B, West CM, Margison GP, Hendry JH: The radiosensitivity of human fibroblast cell lines correlates with residual levels of DNA double-strand breaks.Radiother Oncol 1998, 47: 271-276. 10.1016/S0167-8140(97)00200-4View ArticlePubMedGoogle Scholar
West CM, Davidson SE, Elyan SA, Swindell R, Roberts SA, Orton CJ, Coyle CA, Valentine H, Wilks DP, Hunter RD, Hendry JH: The intrinsic radiosensitivity of normal and tumour cells.Int J Radiat Biol 1998, 73: 409-413. 10.1080/095530098142248View ArticlePubMedGoogle Scholar
Duchaud E, Ridet A, Delic Y, Cundari E, Moustacchi E, Rosselli F: [Changes in the radiation-induced apoptotic response in homozygotes and heterozygotes for the ataxia-telangiectasia gene].C R Acad Sci III 1994, 317: 983-989.PubMedGoogle Scholar
Rosselli F, Ridet A, Soussi T, Duchaud E, Alapetite C, Moustacchi E: p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia.Oncogene 1995, 10: 9-17.PubMedGoogle Scholar
Mori M, Benotmane MA, Tirone I, Hooghe-Peters EL, Desaintes C: Transcriptional response to ionizing radiation in lymphocyte subsets.Cell Mol Life Sci 2005, 62: 1489-1501. 10.1007/s00018-005-5086-3View ArticlePubMedGoogle Scholar
Valerie K, Povirk LF: Regulation and mechanisms of mammalian double-strand break repair.Oncogene 2003, 22: 5792-5812. 10.1038/sj.onc.1206679View ArticlePubMedGoogle Scholar
Cann KL, Hicks GG: Regulation of the cellular DNA double-strand break response.Biochem Cell Biol 2007, 85: 663-674. 10.1139/O07-135View ArticlePubMedGoogle Scholar
Sionov RV, Haupt Y: The cellular response to p53: the decision between life and death.Oncogene 1999, 18: 6145-6157. 10.1038/sj.onc.1203130View ArticlePubMedGoogle Scholar
Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y: Enhanced phosphorylation of p53 by ATM in response to DNA damage.Science 1998, 281: 1674-1677. 10.1126/science.281.5383.1674View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.